Cai Ling-bo, Feng Ting, Chen Juan, Qian Yun, Liu Jia-yin, Zhang Yan
Reproductive Medicine Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Zhonghua Nan Ke Xue. 2005 Dec;11(12):895-6, 899.
To evaluate whether or not intracytoplasmic sperm injection (ICSI) can improve previous fertilization limitation on conventional in vitro fertilization (IVF).
One hundred and thirty-six completed cycles in 113 patients with ICSI treatment were grouped. Group 1 was 106 cycles perform ICSI because of male factor, and group 2 was other 30 cycles with the history of fertilization failure and fertilization rate < 20% on conventional IVF, also assembling the cycles in group 2 according to the fertilization rate.
There was no significant difference between two groups in the rates of normal fertilization(70.49% vs 72.02%), good quality embryos (38.28% vs 38.81%), and clinical pregnancy (40.57% vs 40.00%) (P > 0.05). The fertilization rate of a majority of cycles (70.00%, 21/30) in group 2 was higher than 50%, and the mean of fertilization rates was 79.79%.
ICSI can improve the fertilization limitation following IVF during previous cycles, and the fertilization rates was similar to those treated ICSI because of male factor.
评估卵胞浆内单精子注射(ICSI)能否改善既往常规体外受精(IVF)的受精限制。
对113例行ICSI治疗的患者的136个完整周期进行分组。第1组为因男性因素行ICSI的106个周期,第2组为既往常规IVF受精失败且受精率<20%的其他30个周期,并根据受精率对第2组的周期进行分组。
两组在正常受精率(70.49%对72.02%)、优质胚胎率(38.28%对38.81%)和临床妊娠率(40.57%对40.00%)方面无显著差异(P>0.05)。第2组大多数周期(70.00%,21/30)的受精率高于50%,受精率均值为79.79%。
ICSI可改善既往周期IVF后的受精限制,且受精率与因男性因素行ICSI治疗的相似。